SII stopped manufacturing Covishield since December 2021, says 'disclosed side effects details in packaging insert'

Credit: IndiaTimes- Published on May 8, 2024
SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing authorisations globally. European Medicines Agency confirms Vaxzevria discontinuation in EU.

You are here


💡 newsR Knowledge: Other News Mentions

You might like